News

In The News In our latest report, we took a close examination of the top 25 hospital chargemasters and their efforts to bring transparency to pricing
In The News ADVI’s Lindsay Bealor Greenleaf sat down with Fortune to discuss the latest executive order from the White House and how it will affect Medicare Advantage
In The News ADVI’s Lindsay Bealor Greenleaf caught up with BioWorld to discuss drug prices and how recent proposals would impact patient access to new cures and treatments.
In The News ADVI’s Lindsay Bealor Greenleaf caught up with FierceHealthcare to discuss the latest drug pricing proposal from Speaker Pelosi and the outlook on compromise with both Senate HELP and Finance committee efforts
In The News ADVI Director Lindsay Bealor Greenleaf discussed House Democrats’ drug pricing proposal with Pink Sheet
In The News ADVI’s Lindsay Bealor Greenleaf spoke with FierceHealthcare about competition in the pharmacy space and what CVS’ presence signals for others entering the market
In The News ADVI’s Lindsay Bealor Greenleaf shared her thoughts on the implications of drug importation and the administration’s evolving policies with Bloomberg Law
In The News In her conversation with BioWorld, ADVI’s Lindsay Bealor Greenleaf shared her thoughts on the White House’s decision to withdraw the rebate rule, the impacts of the IPI model, and the role of pharmacy benefit managers in the drug supply chain
In The News ADVI’s Lindsay Bealor Greenleaf discussed the White House’s decision to withdraw the anticipated rebate rule aimed at reforming the drug supply chain and lowering prescription out-of-pocket costs